Wai Conrad's Form 4 filing
Clover Health Investments, Corp. (CLOV) · filed Jul 24, 2025
- Accession no.
- 0001801170-25-000176
- Filed
- Jul 24, 2025
- Trade date
- Jul 22-23, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $693.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wai ConradCIK 0001971702 | Officer (CEO, Counterpart Health) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2025 | Class A Common Stock | SSaleDisposed | −118,600 | $3.29 | −$390,194 | 1,494,898 | Indirect | |
| Jul 23, 2025 | Class A Common Stock | SSaleDisposed | −91,197 | $3.32 | −$302,774.04 | 1,403,701 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.